07 Jan 2001

Duspatalin 135 - España

Updated: 07 Jan 2001

Duspatalin 135 mg 60 grageas

- Síndrome del colon irritable primario y otras patologías relacionadas: colon irritable crónico, estreñimiento espástico, colitis mucosa, colitis espástica. La mebeverina se utiliza para tratar los síntomas de dolor, calambres abdominales persistentes, diarrea no específica (con o sin estreñimiento alternante) y sensación de plenitud. - Espasmos gastrointestinales secundarios a enfermedades orgánicas: diverticulosis y diverticulitis. - Enteriris.

Duspatalin 135 Description, Presentation and Dosage

Duspatalin 135 Description

Duspatalin 135 Drug Class Description

Antiespasmodicos no anticolinergicos

Duspatalin 135 Drug Description

GRAGEAS

Duspatalin 135 Presentation

Duspatalin 135 Presentation

Vía oral: 135 mg/8 h, 20 min antes de las comidas. A menudo es necesario un mes o más de tratamiento.

Duspatalin 135 Manufacturer

SOLVAY PHARMA

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Duspatalin 135 Dosage

Duspatalin 135 Child Dosage

No se dispone de suficiente experiencia clínica en este grupo de edad. Uso no recomendado.

Duspatalin 135 Elderly Dosage

No se han descrito problemas específicos en pacientes geriátricos.

Duspatalin 135 Precautions, Reactions and Contraindications

Duspatalin 135 Special Precautions

Duspatalin 135 Adverse Reactions

Duspatalin 135 Adverse Reactions

Los efectos adversos de mebeverina son, en general, leves y transitorios. Las reacciones adversas más características son: -Excepcionalmente (<<1%): mareos, cefalea, taquicardia, alteraciones del sueño, urticaria, erupciones exantemáticas.

Related Drugs - Gastroenterologia

Back to top